Supplementary Figure 3 from Precision Chemoradiotherapy for HER2 Tumors Using Antibody Conjugates of an Auristatin Derivative with Reduced Cell Permeability
Year: 2023
Type: supplementary-materials
Abstract: T-MMAE stability and bystander cytotoxicity in HER2 negative cells.
Language: English
Subfield: Radiology, Nuclear Medicine and Imaging
Field: Medicine
Domain: Health Sciences
Open Access status: gold
OpenAlex ID: W4362528484
